These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 17934391)

  • 1. A practical approach to reducing cardiovascular risk factors.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S25-36. PubMed ID: 17934391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes].
    Madsbad S; Larsen ML; Adeler HF; Kryhlmand M; Westergaard M
    Ugeskr Laeger; 2006 Apr; 168(17):1640-5. PubMed ID: 16674875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 6. Management strategies to meet the core heart failure measures for acute decompensated heart failure: a nursing perspective.
    Gardetto NJ; Carroll KC
    Crit Care Nurs Q; 2007; 30(4):307-20. PubMed ID: 17873567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.
    Kones R
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):61-81. PubMed ID: 21183531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
    [No Abstract]   [Full Text] [Related]  

  • 9. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical and evidence-based approach to cardiovascular disease risk reduction.
    Gluckman TJ; Baranowski B; Ashen MD; Henrikson CA; McAllister M; Braunstein JB; Blumenthal RS
    Arch Intern Med; 2004 Jul; 164(14):1490-500. PubMed ID: 15277278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American Heart Association Get With The Guidelines program.
    Smaha LA;
    Am Heart J; 2004 Nov; 148(5 Suppl):S46-8. PubMed ID: 15514634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [When should we start the treatment of the cardiovascular risk factors].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2008; 125(1):125-36; discussion 136-44. PubMed ID: 18777847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 16. The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.
    Wenger NK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):118-9. PubMed ID: 20233978
    [No Abstract]   [Full Text] [Related]  

  • 17. The cardiovascular prevention and lifestyle quiz for cardiologists.
    De Sutter J; Conraads VM
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S8-10. PubMed ID: 19675443
    [No Abstract]   [Full Text] [Related]  

  • 18. Awareness of cardiovascular risk factors in ischaemic heart disease: implications during the projection of secondary prevention interventions.
    Montinaro S; Mazzetti S; Vasicuro C; Acquistapace F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1052-6. PubMed ID: 18799969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline implementation research: exploring the gap between evidence and practice in the CRUSADE Quality Improvement Initiative.
    Blomkalns AL; Roe MT; Peterson ED; Ohman EM; Fraulo ES; Gibler WB
    Acad Emerg Med; 2007 Nov; 14(11):949-54. PubMed ID: 17967956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary stroke prevention.
    Rincon F; Sacco RL
    J Cardiovasc Nurs; 2008; 23(1):34-41; quiz 42-3. PubMed ID: 18158505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.